Return
Interleukin-18
DOI:10.1189/jlb.0602313.png)
Abstract
En 中文
Interleukin-18 (IL-18), a recently described member of the IL-1 cytokine superfamily, is now recognized as an important regulator of innate and acquired immune responses. IL-18 is expressed at sites of chronic inflammation, in antoimmune diseases, in a variety of cancers, and in the context of numerous infectious diseases. This short review will describe the basic biology of IL-18 and thereafter address its potential effector and regulatory role in several human disease states including autoimmunity and infection. IL-18, previously known as interferon-gamma (IFN-gamma)-inducing factor, was identified as an endotoxin-induced serum factor that stimulated IFN-gamma production by murine splenocytes [1]. IL-18 was cloned from a murine liver cell cDNA library generated from animals primed with heat-killed Propionibacterium acnes and subsequently challenged with lipopolysaccharide [2]. Nucleotide sequencing of murine IL-18 predicted a precursor polypeptide of 192 amino acids lacking a conventional signal peptide and a mature protein of 157 amino acids. Subsequent cloning of human IL-18 cDNA revealed 65% homology with murine IL-18 [3] and showed that both contain an unusual leader sequence consisting of 35 amino acids at their N terminus.
Keywords:
cytokine
inflammation
autoimmunity
infectious disease
interleukin-18
Journal
IF:
3.1
Papers:
6.9K
Citations:
1.8W
Organization
No organization information available
Cited Papers
Improved specificity toward substrates with positively charged side chains by site-directed mutagenesis of the L-lactate dehydrogenase of Bacillus stearothermophilus
Biochemistry
IF0
Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing Type I diabetes
DIABETOLOGIA
IF10.2
NHC-catalyzed annulation of enals and chalcones: further explorations on the novel synthesis of 1,3,4-trisubstituted cyclopentenes
Tetrahedron
IF0

